Merck's most recent trend suggests a bullish bias. One trading opportunity on Merck is a Bull Put Spread using a strike $86.00 short put and a strike $81.00 long put offers a potential 25.63% return on risk over the next 27 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $86.00 by expiration. The full premium credit of $1.02 would be kept by the premium seller. The risk of $3.98 would be incurred if the stock dropped below the $81.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Merck is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Merck is bullish.
The RSI indicator is at 59.19 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Merck
AstraZeneca's Kidney Drug Roxadustat Gets Second Nod in China
Thu, 22 Aug 2019 22:08:10 +0000
AstraZeneca's (AZN) roxadustat gets a second marketing approval in China for treating anaemia caused by chronic kidney disease in non-dialysis-dependent patients.
Pfizer's Xtandi Label Expansion Filing Gets Priority Review
Thu, 22 Aug 2019 14:20:02 +0000
If data from ARCHES study is approved to be included in the label of Pfizer's (PFE) Xtandi, it can treat a broader prostate cancer patient population.
Glaxo Submits First Regulatory Application for Daprodustat
Thu, 22 Aug 2019 14:07:02 +0000
Glaxo (GSK) seeks approval for its anemia candidate, daprodustat, in Japan. Moreover, once every two months administration of cabotegravir and rilpivirine shows non-inferiority to once a month administration in HIV patients in a clinical study.
Analysts Share Stocks To Buy On Fed Uncertainty
Thu, 22 Aug 2019 12:21:48 +0000
On CNBC's “Trading Nation,” Mark Newton of Newton Advisors recommended Twitter Inc (NYSE: TWTR ) and Merck & Co., Inc. (NYSE: MRK ) as stocks to buy in the current market environment. He said …
Merck Highlights New Data from Leading Lung Cancer Clinical Development Program at the IASLC 2019 World Conference on Lung Cancer
Thu, 22 Aug 2019 10:45:00 +0000
Pooled Overall Survival Data from Three Trials with KEYTRUDA® Plus Chemotherapy in Subgroup of Patients with Non-Small Cell Lung Cancer Whose Tumors Do
Also on Market Tamer…
Follow Us on Facebook